These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 20227773)

  • 1. Differential expression of aquaporin-4 isoforms localizes with neuromyelitis optica disease activity.
    Saini H; Fernandez G; Kerr D; Levy M
    J Neuroimmunol; 2010 Apr; 221(1-2):68-72. PubMed ID: 20227773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aquaporin-4 orthogonal arrays of particles are the target for neuromyelitis optica autoantibodies.
    Nicchia GP; Mastrototaro M; Rossi A; Pisani F; Tortorella C; Ruggieri M; Lia A; Trojano M; Frigeri A; Svelto M
    Glia; 2009 Oct; 57(13):1363-73. PubMed ID: 19229993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis.
    Misu T; Fujihara K; Kakita A; Konno H; Nakamura M; Watanabe S; Takahashi T; Nakashima I; Takahashi H; Itoyama Y
    Brain; 2007 May; 130(Pt 5):1224-34. PubMed ID: 17405762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of aquaporin-4 expression in lesions of neuromyelitis optica but increased expression in multiple sclerosis lesions and normal-appearing white matter.
    Sinclair C; Kirk J; Herron B; Fitzgerald U; McQuaid S
    Acta Neuropathol; 2007 Feb; 113(2):187-94. PubMed ID: 17143632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis.
    Roemer SF; Parisi JE; Lennon VA; Benarroch EE; Lassmann H; Bruck W; Mandler RN; Weinshenker BG; Pittock SJ; Wingerchuk DM; Lucchinetti CF
    Brain; 2007 May; 130(Pt 5):1194-205. PubMed ID: 17282996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuromyelitis optica: changing concepts.
    Jacob A; Matiello M; Wingerchuk DM; Lucchinetti CF; Pittock SJ; Weinshenker BG
    J Neuroimmunol; 2007 Jul; 187(1-2):126-38. PubMed ID: 17512987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression.
    Pittock SJ; Weinshenker BG; Lucchinetti CF; Wingerchuk DM; Corboy JR; Lennon VA
    Arch Neurol; 2006 Jul; 63(7):964-8. PubMed ID: 16831965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica.
    Jarius S; Paul F; Franciotta D; Waters P; Zipp F; Hohlfeld R; Vincent A; Wildemann B
    Nat Clin Pract Neurol; 2008 Apr; 4(4):202-14. PubMed ID: 18334978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuromyelitis Optica Immunoglobulin G present in sera from neuromyelitis optica patients affects aquaporin-4 expression and water permeability of the astrocyte plasma membrane.
    Melamud L; Fernández JM; Rivarola V; Di Giusto G; Ford P; Villa A; Capurro C
    J Neurosci Res; 2012 Jun; 90(6):1240-8. PubMed ID: 22354518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aquaporin 4 expression and tissue susceptibility to neuromyelitis optica.
    Matiello M; Schaefer-Klein J; Sun D; Weinshenker BG
    JAMA Neurol; 2013 Sep; 70(9):1118-25. PubMed ID: 23857303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuromyelitis optica and asian phenotype of multiple sclerosis.
    Kira J
    Ann N Y Acad Sci; 2008 Oct; 1142():58-71. PubMed ID: 18990121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain abnormalities in Sjogren syndrome with recurrent CNS manifestations: association with neuromyelitis optica.
    Min JH; Kim HJ; Kim BJ; Lee KW; Sunwoo IN; Kim SM; Kim BJ; Kim SH; Park MS; Waters P; Vincent A; Sung JJ; Lee KH
    Mult Scler; 2009 Sep; 15(9):1069-76. PubMed ID: 19625331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of AQP4 in neuromyelitis optica: More answers, more questions.
    Yang X; Ransom BR; Ma JF
    J Neuroimmunol; 2016 Sep; 298():63-70. PubMed ID: 27609277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica.
    Hinson SR; Pittock SJ; Lucchinetti CF; Roemer SF; Fryer JP; Kryzer TJ; Lennon VA
    Neurology; 2007 Dec; 69(24):2221-31. PubMed ID: 17928579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuromyelitis optica: new findings on pathogenesis.
    Wingerchuk DM
    Int Rev Neurobiol; 2007; 79():665-88. PubMed ID: 17531863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuromyelitis optica IgG does not alter aquaporin-4 water permeability, plasma membrane M1/M23 isoform content, or supramolecular assembly.
    Rossi A; Ratelade J; Papadopoulos MC; Bennett JL; Verkman AS
    Glia; 2012 Dec; 60(12):2027-39. PubMed ID: 22987455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells.
    Hinson SR; McKeon A; Fryer JP; Apiwattanakul M; Lennon VA; Pittock SJ
    Arch Neurol; 2009 Sep; 66(9):1164-7. PubMed ID: 19752309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neuromyelitis optica and anti-aquaporin 4 antibody--an overview].
    Misu T; Fujihara K; Itoyama Y
    Brain Nerve; 2008 May; 60(5):527-37. PubMed ID: 18516975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effector functions of antiaquaporin-4 autoantibodies in neuromyelitis optica.
    Cayrol R; Saikali P; Vincent T
    Ann N Y Acad Sci; 2009 Sep; 1173():478-86. PubMed ID: 19758189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurological autoimmunity targeting aquaporin-4.
    Hinson SR; McKeon A; Lennon VA
    Neuroscience; 2010 Jul; 168(4):1009-18. PubMed ID: 19699271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.